Esbriet 267 mg by Roche is indicated in adults for the treatment of mild to moderate Idiopathic Pulmonary Fibrosis (IPF).
$55.00 – $110.00
Esbriet 267 mg by Roche is indicated in adults for the treatment of mild to moderate Idiopathic Pulmonary Fibrosis (IPF).